Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B6897 DMeOBSummary: Negative allosteric modulator of mGlu5
- B6931 ROS 234 dioxalateSummary: H3 antagonist
- B6937 SKF 83959 hydrobromideSummary: Dopamine D1-like receptor partial agonist
- B6938 SKF 83822 hydrobromideSummary: dopamine D1-like receptor agonist
- B6949 DAU 5884 hydrochlorideSummary: muscarinic M3 receptor antagonist
- B6952 Paroxetine maleateSummary: 5-HT uptake inhibitor
- B6969 3-MATIDASummary: mGlu1 receptor antagonist
- B6981 ABT 724 trihydrochlorideSummary: Dopamine D4 receptor agonist,potent and selective
- B6990 DMAB-anabaseine dihydrochlorideSummary: α7-containing neuronal nicotinic receptor partial agonist
- B6991 ACDPP hydrochlorideSummary: mGlu5 receptor antagonist